You are reading this message because you cannot see our css files. To view this page properly please upgrade to the latest version of your browser. Thank you.

Biosite licenses cardiovascular research at Mainz University

Licence / Biotechnology

San Diego, USA, 22 August 2005

Research on a potentially important new biomarker for cardiovascular disease is the subject of an exclusive licensing agreement between Johannes Gutenberg University in Mainz, Germany, and Biosite Inc, a diagnostics company based in San Diego, USA.

Press release

ALSO IN THIS SECTION

Roche buys Zürich spin-off
Cambridge forms 'club' for seed investing
Faster DNA sequencing hope from EU-backed project
VCs pile into hologram start-up
New asthma tests coming from Sweden
UV tester Paraytec gets £170,000
Oxford T-cell diagnostics raise £7M
Intercytex cell therapy draws £12M investment
Biosite licenses cardiovascular research at Mainz University
BTG licenses online-tracking patents to Netflix, settling lawsuit
Thiakis obesity-hormone firm gets licence payment
Home fuel-cell development planned by British Gas, Ceres Power
Three UK testing services join forces
BP funds $14M Oxford centre to study the "resource curse"

http://www.sciencebusiness.net |
Privacy policy |
Contact Us